For example, the cerebrospinal fluid (CSF) biomarkers amyloid-β (Aβ42), total tau and phosphorylated tau can serve as early markers of Alzheimer's disease and thus provide clinically relevant diagnostic information (Blennow and Zetterberg, 2018). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.